You just read:

CTI BioPharma Announces European Medicines Agency Validation of Pacritinib Marketing Authorization Application for Patients with Myelofibrosis who have Thrombocytopenia

News provided by

CTI BioPharma Corp.

Jul 13, 2017, 16:05 ET